Dan Sorine

Dan Sorine is a seasoned marketing professional with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as Director of RHU/GI Access Marketing at Pfizer, Dan Sorine is broadening expertise in payer and market access landscapes. Previously, as Director of GI Marketing, Dan Sorine led HCP efforts for XELJANZ’s ulcerative colitis indication, achieving notable quarter-over-quarter growth in new prescriptions. At Eisai US, Dan Sorine held the role of Senior Manager in Oncology Marketing, overseeing HCP promotions for a significant collaboration with Merck Oncology on the launch of KEYTRUDA + LENVIMA. Dan Sorine's earlier positions include Vice President roles at CDM New York and The ADVERTISING Club of New York, along with various account management roles across companies such as Genentech and Area 23. Dan Sorine holds an MBA from NYU Stern School of Business and a Bachelor’s degree from Fordham University.